SCHEMBL5269435

SCHEMBL5269435

CCCc1cccc(C(=O)OC)n1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.50
MRGPRX4 Q96LA9 2/20 0.50
PARP1 P09874 1/20 0.47
MAPT P10636 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
GRM5 P41594 1/20 0.45
ADORA2A P29274 1/20 0.44
PTGER4 P35408 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25137284 0.89 KCNH2 (0.57) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL16834473 0.87 MRGPRX4 (0.50) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL6117260 0.86 CYP1A2 (0.53) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL9993619 0.85 CYP1A2 (0.72) CYP1A2MAPTSMN1; SMN2GAANPC1
SCHEMBL19837350 0.85 ALDH1A1 (0.50) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL27886031 0.85 MRGPRX4 (0.49) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL2348677 0.84 MRGPRX4 (0.48) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL7671391 0.83 MRGPRX4 (0.52) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL30022926 0.83 MRGPRX4 (0.52) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2
SCHEMBL183978 0.83 MRGPRX4 (0.52) CYP1A2MRGPRX4PARP1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397364-B1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS LILLY CO ELI (US) 2007-07-25 EP disclosed
WO-2004026302-A1 METHODS OF INHIBITING TGF BETA WITH SUBSTITUTED PYRAZOLES ELI LILLY AND COMPANY (US) 2004-04-01 WO disclosed